Oaktree Specialty Lending Corporation (OCSL)
NASDAQ: OCSL · Real-Time Price · USD
14.61
+0.16 (1.11%)
At close: Jul 16, 2025, 4:00 PM
14.55
-0.06 (-0.41%)
After-hours: Jul 16, 2025, 4:02 PM EDT

Company Description

Oaktree Specialty Lending Corporation is a business development company.

The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies.

It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering.

The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors.

It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies.

The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million.

The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America.

The fund seeks to be a lead investor in its portfolio companies.

Oaktree Specialty Lending Corporation
Oaktree Specialty Lending logo
CountryUnited States
Founded2007
IPO DateJun 12, 2008
IndustryAsset Management
SectorFinancials
CEOArmen Panossian

Contact Details

Address:
333 South Grand Avenue, 28th Floor
Los Angeles, California 90071
United States
Phone213 830 6300
Websiteoaktreespecialtylending.com

Stock Details

Ticker SymbolOCSL
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearOctober - September
Reporting CurrencyUSD
CIK Code0001414932
CUSIP Number67401P108
ISIN NumberUS67401P4054
Employer ID26-1219283

Key Executives

NamePosition
Armen Panossian J.D.Chief Executive Officer and Co-Chief Investment Officer
Mathew M. PendoPresident
Dr. Aman Kumar M.D.Managing Director and Co-Portfolio Manager of Life Sciences Direct Lending
Christopher McKownMD,Chief Financial Officer and Treasurer
Raghav KhannaCo-Chief Investment Officer
Dane KlevenSenior Vice President and Head of Investor Relations
Mary Gallegly J.D.MD,General Counsel and Secretary
Ashley PakChief Compliance Officer
Sandeep Kumar KhoranaManaging Director of Origination
Eric JohnsonManaging Director

Latest SEC Filings

DateTypeTitle
May 16, 20258-KCurrent Report
May 5, 2025424B5Filing
May 5, 20258-KCurrent Report
May 1, 20258-KCurrent Report
May 1, 202510-QQuarterly Report
Apr 11, 20258-KCurrent Report
Mar 5, 20258-KCurrent Report
Feb 27, 20258-KCurrent Report
Feb 24, 2025424B2Prospectus
Feb 21, 20258-KCurrent Report